Aliskiren

Details

Files

Generic Name:

Aliskiren

Project Status:

Complete

Therapeutic Area:

Hypertension

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Rasilez

Project Line:

Reimbursement Review

Project Number:

SR0118-000

Submission Type:

Initial

Indications:

Hypertension

Recommendation Type:

Do not list

Final Recommendation:

June 25, 2008

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : November 30, 2007